成都新恒創(chuàng)藥業(yè)有限公司創(chuàng)立于2006年，歷經(jīng)7年發(fā)展，以卓越的研發(fā)、生產(chǎn)能力，杰出的經(jīng)營(yíng)管理水平得到社會(huì)各界的充分肯定。

　　　歷年來(lái)榮獲的省市級(jí)以上榮譽(yù)稱號(hào)和資質(zhì)證書(shū)達(dá)數(shù)十種之多 ?，F(xiàn)已成為醫(yī)藥原料藥含醫(yī)藥中間體生產(chǎn)為主，集科研、生產(chǎn)、貿(mào)易于一體的現(xiàn)代化醫(yī)藥企業(yè)，它坐落于產(chǎn)業(yè)開(kāi)發(fā)園內(nèi)成都溫江海峽兩岸科技產(chǎn)業(yè)開(kāi)發(fā)園，公司占地面積40畝。企業(yè) 下設(shè)獨(dú)立的新產(chǎn)品研發(fā)、生產(chǎn)、中試及營(yíng)銷中心。

　　　成都新恒創(chuàng)藥業(yè)有限公司曾與國(guó)內(nèi)多家知名藥企進(jìn)行新藥項(xiàng)目合作，并建立了良好的合作關(guān)系。目前公司已聚集了一批以留美博士、資深藥物專家、教授領(lǐng)軍的新藥研究人才，形成了較強(qiáng)的新藥技術(shù)研發(fā)能力，公司與中國(guó)科學(xué)院成都分院、國(guó)家藥品監(jiān)督管理局四川抗菌素工業(yè)研究所、成都中醫(yī)藥大學(xué)、四川大學(xué) (華西醫(yī)科大學(xué))等高等學(xué)府及科研機(jī)構(gòu)建立了專家咨詢制度及良好的長(zhǎng)期合作關(guān)系。

　　　新恒創(chuàng)自成立以來(lái)，陸續(xù)開(kāi)發(fā)了一系列高附加值的優(yōu)質(zhì)品種。公司主要經(jīng)營(yíng)產(chǎn)品：甲磺酸多拉司瓊、羅庫(kù)溴銨、鹽酸帕洛諾司瓊、琥珀酸索非那新、琥珀酸普蘆卡必利、鹽酸替羅非班、鹽酸普拉克索、格隆溴銨、利奈唑胺、鹽酸法舒地爾、氫溴酸達(dá)非那新、鹽酸莫西沙星、甲磺酸吉米沙星、佐芬普利鈣、酒石酸阿福莫特羅、鹽酸阿扎司瓊、伏立康唑、吉非替尼、鹽酸埃羅替尼、枸櫞酸托法替尼、阿哌沙班、帕瑞昔布鈉、埃索美拉唑鈉、右旋蘭索拉唑、右**、阿戈美拉汀、米力農(nóng)等醫(yī)藥原料及其醫(yī)藥中間體， 市場(chǎng)前景非常廣闊。

　　成都新恒創(chuàng)藥業(yè)有限公司不斷進(jìn)取，在化學(xué)合成藥物以及中間體的研發(fā)生產(chǎn)上形成自有體系，并不斷推出優(yōu)勢(shì)品種，公司將秉承“誠(chéng)信待人，創(chuàng)新無(wú)限”的企業(yè)原則，發(fā)揚(yáng)“天道酬勤、人道酬誠(chéng)、業(yè)道酬精”的企業(yè)**，始終以“創(chuàng)建的國(guó)際性制藥企業(yè)，造福人類”為企業(yè)目標(biāo)， 以新技術(shù)、新產(chǎn)品的不斷更新來(lái)適應(yīng)和滿足 國(guó)內(nèi)外市場(chǎng)的各種變化及需求，創(chuàng)建的國(guó)際性制藥企業(yè)。

　　　追求品質(zhì)，精益求精，是新恒創(chuàng)藥業(yè)經(jīng)營(yíng)的一貫理念，我們期待與您共創(chuàng)美好未來(lái)。

　　　Chengdu Sino-Strong Pharmaceutical Co., Ltd. was establised in 2006 which specialized in the new drugs research, the manufacture of new APIs, and pharmaceutical raw materials and intermediates. It is located in national industrial park named Chengdu wenjiang cross-straits technological industrial park with an area of 27.Ourcompany is well-known for the outstanding research, production capability and also good management .

　　　Sino-strong consists of R&D Center, Production Center, Testing Center and Marketing Center. Our company has the advanced technology in the multi-step synthesis and the new route development of self-intellectual property rights .

　　　Our company have cooperated with national famous pharmaceutical for new drugs projects and kept good business relationship with them . There are doctors , senior medical experts and professors of organic chemistry which form a strong research team and conduct powerful technological research capability . Our company also set up experts consulting systems and established long-terms business relationship with the universities and S & R institutes as following , Chinese Academy of Sciences Chengdu Branch, SFDA Industrial Institute of Antibiotics in Sichuan, Chengdu University of Chinese medicine, Sichuan University( Huaxi Medical University ) ...

　　　Since establishment , it has developed series of high value superior products . The main range is as following : Rocuronium Bromide, Palonosetron Hydrochloride, Solifenacin Succinate, Prucalopride Succinate, Tirofiban Hydrochloride, Pramipexole Dihydrochloride, Glycopyrronium Bromide, Linezolid,Dolasetron Mesylate, Fasudil Hydrochloride, Darifenacin Hydrobromide, Moxifloxacin Hydrochloride, Gemifioxacin Mesylate, Zofenopril Calcium,Arformoterol Tartrate, Azasetron Hydrochloride, Voriconazole, Gefitinib, Erlotinib Hydrochloride, Tofacitinib citrate... Such APIs and the intermediates which are very popular among domestic market and also abroad . 

　　　Sino-strong is progressive in the multi-step synthesis and new intermediates development, which can launch new superior products continuously .

　　　Our consistent idea is pursuit of quality and excelsior, we are looking forward to creating a bright future with you .